{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:29:58Z","timestamp":1793690998433,"version":"4.5.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,5]]},"DOI":"10.7759\/cureus.96126","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T10:35:57Z","timestamp":1762338957000},"source":"Crossref","is-referenced-by-count":2,"title":["Biomarkers of Probiotic Therapy in Ulcerative Colitis: A Systematic Review of Mechanisms Underlying Remission"],"prefix":"10.7759","author":[{"given":"Mohammad E","family":"Farhad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Belal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Baana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Childs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moussa","family":"Al-Rufayie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X13482996","article-title":"Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ","volume":"6","author":"Guinane CM","year":"2013","unstructured":"Guinane CM, Cotter PD. Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ. Therap Adv Gastroenterol. 2013, 6:295-308. 10.1177\/1756283X13482996","journal-title":"Therap Adv Gastroenterol"},{"key":"ref2","article-title":"Gut bacteria in health and disease","volume":"9","author":"Quigley EM","year":"2013","unstructured":"Quigley EM. Gut bacteria in health and disease. Gastroenterol Hepatol. 2013, 9:560-9.","journal-title":"Gastroenterol Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i29.8787","article-title":"Role of the normal gut microbiota","volume":"21","author":"Jandhyala SM","year":"2015","unstructured":"Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Nageshwar Reddy D. Role of the normal gut microbiota. World J Gastroenterol. 2015, 21:8787-803. 10.3748\/wjg.v21.i29.8787","journal-title":"World J Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k2179","article-title":"Role of the gut microbiota in nutrition and health","volume":"361","author":"Valdes AM","year":"2018","unstructured":"Valdes AM, Walter J, Segal E, Spector TD. Role of the gut microbiota in nutrition and health. BMJ. 2018, 361:k2179. 10.1136\/bmj.k2179","journal-title":"BMJ"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/ijpo.12217","article-title":"The prenatal gut microbiome: are we colonized with bacteria in utero?","volume":"12","author":"Walker RW","year":"2017","unstructured":"Walker RW, Clemente JC, Peter I, Loos RJ. The prenatal gut microbiome: are we colonized with bacteria in utero?. Pediatr Obes. 2017, 12:3-17. 10.1111\/ijpo.12217","journal-title":"Pediatr Obes"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12567","article-title":"Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease","volume":"279","author":"Pickard JM","year":"2017","unstructured":"Pickard JM, Zeng MY, Caruso R, N\u00fa\u00f1ez G. Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease. Immunol Rev. 2017, 279:70-89. 10.1111\/imr.12567","journal-title":"Immunol Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1503\/jpn.190110","article-title":"The microbiome and mental health: Hope or hype?","volume":"44","author":"Taylor VH","year":"2019","unstructured":"Taylor VH. The microbiome and mental health: Hope or hype?. J Psychiatry Neurosci. 2019, 44:219-22. 10.1503\/jpn.190110","journal-title":"J Psychiatry Neurosci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-017-1445-8","article-title":"Gut microbiota functions: metabolism of nutrients and other food components","volume":"57","author":"Rowland I","year":"2018","unstructured":"Rowland I, Gibson G, Heinken A, Scott K, Swann J, Thiele I, Tuohy K. Gut microbiota functions: metabolism of nutrients and other food components. Eur J Nutr. 2018, 57:1-24. 10.1007\/s00394-017-1445-8","journal-title":"Eur J Nutr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-322670","article-title":"Long-term dietary patterns are associated with pro-inflammatory and anti-inflammatory features of the gut microbiome","volume":"70","author":"Bolte LA","year":"2021","unstructured":"Bolte LA, Vich Vila A, Imhann F, et al.. Long-term dietary patterns are associated with pro-inflammatory and anti-inflammatory features of the gut microbiome. Gut. 2021, 70:1287-98. 10.1136\/gutjnl-2020-322670","journal-title":"Gut"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms7080271","article-title":"The role of gut microbiota in intestinal inflammation with respect to diet and extrinsic stressors","volume":"7","author":"Lobionda S","year":"2019","unstructured":"Lobionda S, Sittipo P, Kwon HY, Lee YK. The role of gut microbiota in intestinal inflammation with respect to diet and extrinsic stressors. Microorganisms. 2019, 7:271. 10.3390\/microorganisms7080271","journal-title":"Microorganisms"},{"key":"ref11","unstructured":"Ulcerative colitis. NHS. (2020). Accessed. 21 August 2020: https:\/\/www.nhs.uk\/conditions\/ulcerative-colitis\/."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/gut.50.2.170","article-title":"Microflora reactive IL-10 producing regulatory T cells are present in the colon of IL-2 deficient mice but lack efficacious inhibition of IFN-gamma and TNF-alpha production","volume":"50","author":"Waidmann M","year":"2002","unstructured":"Waidmann M, Allemand Y, Lehmann J, di Genaro S, B\u00fccheler N, Hamann A, Autenrieth IB. Microflora reactive IL-10 producing regulatory T cells are present in the colon of IL-2 deficient mice but lack efficacious inhibition of IFN-gamma and TNF-alpha production. Gut. 2002, 50:170-9. 10.1136\/gut.50.2.170","journal-title":"Gut"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i3.1078","article-title":"Role of antibiotics for treatment of inflammatory bowel disease","volume":"22","author":"Nitzan O","year":"2016","unstructured":"Nitzan O, Elias M, Peretz A, Saliba W. Role of antibiotics for treatment of inflammatory bowel disease. World J Gastroenterol. 2016, 22:1078-87. 10.3748\/wjg.v22.i3.1078","journal-title":"World J Gastroenterol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph110504745","article-title":"Microorganisms with claimed probiotic properties: an overview of recent literature","volume":"11","author":"Fijan S","year":"2014","unstructured":"Fijan S. Microorganisms with claimed probiotic properties: an overview of recent literature. Int J Environ Res Public Health. 2014, 11:4745-67. 10.3390\/ijerph110504745","journal-title":"Int J Environ Res Public Health"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/cells12010184","article-title":"Probiotics mechanism of action on immune cells and beneficial effects on human health","volume":"12","author":"Mazziotta C","year":"2023","unstructured":"Mazziotta C, Tognon M, Martini F, Torreggiani E, Rotondo JC. Probiotics mechanism of action on immune cells and beneficial effects on human health. Cells. 2023, 12:184. 10.3390\/cells12010184","journal-title":"Cells"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/01.MIB.0000437495.30052.be","article-title":"Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: meta-analysis of randomized controlled trials","volume":"20","author":"Shen J","year":"2014","unstructured":"Shen J, Zuo ZX, Mao AP. Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: meta-analysis of randomized controlled trials. Inflamm Bowel Dis. 2014, 20:21-35. 10.1097\/01.MIB.0000437495.30052.be","journal-title":"Inflamm Bowel Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2174\/1871530319666181221150352","article-title":"Probiotics efficacy on oxidative stress values in inflammatory bowel disease: a randomized double-blinded placebo-controlled pilot study","volume":"19","author":"Ballini A","year":"2019","unstructured":"Ballini A, Santacroce L, Cantore S, et al.. Probiotics efficacy on oxidative stress values in inflammatory bowel disease: a randomized double-blinded placebo-controlled pilot study. Endocr Metab Immune Disord Drug Targets. 2019, 19:373-81. 10.2174\/1871530319666181221150352","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-019-00595-4","article-title":"A randomised, double-blind, placebo-controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and Crohn's disease","volume":"27","author":"Bjarnason I","year":"2019","unstructured":"Bjarnason I, Sission G, Hayee B. A randomised, double-blind, placebo-controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and Crohn's disease. Inflammopharmacology. 2019, 27:465-73. 10.1007\/s10787-019-00595-4","journal-title":"Inflammopharmacology"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.5152\/tjg.2019.18426","article-title":"Effects of pentasa-combined probiotics on the microflora structure and prognosis of patients with inflammatory bowel disease","volume":"30","author":"Fan H","year":"2019","unstructured":"Fan H, Du J, Liu X, Zheng WW, Zhuang ZH, Wang CD, Gao R. Effects of pentasa-combined probiotics on the microflora structure and prognosis of patients with inflammatory bowel disease. Turk J Gastroenterol. 2019, 30:680-5. 10.5152\/tjg.2019.18426","journal-title":"Turk J Gastroenterol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v16.i33.4145","article-title":"Effect of probiotics on pro-inflammatory cytokines and NF-kappaB activation in ulcerative colitis","volume":"16","author":"Hegazy SK","year":"2010","unstructured":"Hegazy SK, El-Bedewy MM. Effect of probiotics on pro-inflammatory cytokines and NF-kappaB activation in ulcerative colitis. World J Gastroenterol. 2010, 16:4145-51. 10.3748\/wjg.v16.i33.4145","journal-title":"World J Gastroenterol"},{"key":"ref21","article-title":"Efficacy of mesalazine in combination with bifid triple viable capsules on ulcerative colitis and the resultant effect on the inflammatory factors","volume":"31","author":"Huang M","year":"2018","unstructured":"Huang M, Chen Z, Lang C, Chen J, Yang B, Xue L, Zhang Y. Efficacy of mesalazine in combination with bifid triple viable capsules on ulcerative colitis and the resultant effect on the inflammatory factors. Pak J Pharm Sci. 2018, 31:2891-5.","journal-title":"Pak J Pharm Sci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1080\/07315724.2003.10719276","article-title":"Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis","volume":"22","author":"Ishikawa H","year":"2003","unstructured":"Ishikawa H, Akedo I, Umesaki Y, Tanaka R, Imaoka A, Otani T. Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis. J Am Coll Nutr. 2003, 22:56-63. 10.1080\/07315724.2003.10719276","journal-title":"J Am Coll Nutr"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02268.x","article-title":"Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis","volume":"20","author":"Kato K","year":"2004","unstructured":"Kato K, Mizuno S, Umesaki Y, et al.. Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis. Aliment Pharmacol Ther. 2004, 20:1133-41. 10.1111\/j.1365-2036.2004.02268.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.037747","article-title":"Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine","volume":"53","author":"Kruis W","year":"2004","unstructured":"Kruis W, Fric P, Pokrotnieks J, et al.. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut. 2004, 53:1617-23. 10.1136\/gut.2003.037747","journal-title":"Gut"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/404752","article-title":"The effect of bifid triple viable on immune function of patients with ulcerative colitis","volume":"2012","author":"Li G","year":"2012","unstructured":"Li G, Zeng S, Liao W, Lv N. The effect of bifid triple viable on immune function of patients with ulcerative colitis. Gastroenterol Res Pract. 2012, 2012:404752. 10.1155\/2012\/404752","journal-title":"Gastroenterol Res Pract"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2010.11.004","article-title":"A randomised double-blind placebo-controlled trial with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 for maintenance of remission in ulcerative colitis","volume":"5","author":"Wildt S","year":"2011","unstructured":"Wildt S, Nordgaard I, Hansen U, Brockmann E, Rumessen JJ. A randomised double-blind placebo-controlled trial with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 for maintenance of remission in ulcerative colitis. J Crohns Colitis. 2011, 5:115-21. 10.1016\/j.crohns.2010.11.004","journal-title":"J Crohns Colitis"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21222","article-title":"Immunosuppressive effects via human intestinal dendritic cells of probiotic bacteria and steroids in the treatment of acute ulcerative colitis","volume":"16","author":"Ng SC","year":"2010","unstructured":"Ng SC, Plamondon S, Kamm MA, et al.. Immunosuppressive effects via human intestinal dendritic cells of probiotic bacteria and steroids in the treatment of acute ulcerative colitis. Inflamm Bowel Dis. 2010, 16:1286-98. 10.1002\/ibd.21222","journal-title":"Inflamm Bowel Dis"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.5152\/tjg.2018.18227","article-title":"Effect of administering kefir on the changes in fecal microbiota and symptoms of inflammatory bowel disease: a randomized controlled trial","volume":"30","author":"Y\u0131lmaz \u0130","year":"2019","unstructured":"Y\u0131lmaz \u0130, Dolar ME, \u00d6zp\u0131nar H. Effect of administering kefir on the changes in fecal microbiota and symptoms of inflammatory bowel disease: a randomized controlled trial. Turk J Gastroenterol. 2019, 30:242-53. 10.5152\/tjg.2018.18227","journal-title":"Turk J Gastroenterol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v10.i10.1521","article-title":"Effects of probiotic on intestinal mucosa of patients with ulcerative colitis","volume":"10","author":"Cui HH","year":"2004","unstructured":"Cui HH, Chen CL, Wang JD, et al.. Effects of probiotic on intestinal mucosa of patients with ulcerative colitis. World J Gastroenterol. 2004, 10:1521-5. 10.3748\/wjg.v10.i10.1521","journal-title":"World J Gastroenterol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.59009","article-title":"C-reactive protein: An inflammatory biomarker and a predictor of neurodegenerative disease in patients with inflammatory bowel disease?","volume":"16","author":"Muresan S","year":"2024","unstructured":"Muresan S, Slevin M. C-reactive protein: An inflammatory biomarker and a predictor of neurodegenerative disease in patients with inflammatory bowel disease?. Cureus. 2024, 16:e59009. 10.7759\/cureus.59009","journal-title":"Cureus"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/586092","article-title":"Mesalazine in inflammatory bowel disease: a trendy topic once again?","volume":"24","author":"Iacucci M","year":"2010","unstructured":"Iacucci M, de Silva S, Ghosh S. Mesalazine in inflammatory bowel disease: a trendy topic once again?. Can J Gastroenterol. 2010, 24:127-33. 10.1155\/2010\/586092","journal-title":"Can J Gastroenterol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/nature06005","article-title":"Unravelling the pathogenesis of inflammatory bowel disease","volume":"448","author":"Xavier RJ","year":"2007","unstructured":"Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007, 448:427-34. 10.1038\/nature06005","journal-title":"Nature"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1038\/nri3430","article-title":"Role of the gut microbiota in immunity and inflammatory disease","volume":"13","author":"Kamada N","year":"2013","unstructured":"Kamada N, Seo SU, Chen GY, N\u00fa\u00f1ez G. Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol. 2013, 13:321-35. 10.1038\/nri3430","journal-title":"Nat Rev Immunol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2007.10.004","article-title":"Dendritic cells and cytokines in human inflammatory and autoimmune diseases","volume":"19","author":"Blanco P","year":"2008","unstructured":"Blanco P, Palucka AK, Pascual V, Banchereau J. Dendritic cells and cytokines in human inflammatory and autoimmune diseases. Cytokine Growth Factor Rev. 2008, 19:41-52. 10.1016\/j.cytogfr.2007.10.004","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.41120","article-title":"Advancements in inflammatory bowel disease: a narrative review of diagnostics, management, epidemiology, prevalence, patient outcomes, quality of life, and clinical presentation","volume":"15","author":"Muzammil MA","year":"2023","unstructured":"Muzammil MA, Fariha F, Patel T, et al.. Advancements in inflammatory bowel disease: a narrative review of diagnostics, management, epidemiology, prevalence, patient outcomes, quality of life, and clinical presentation. Cureus. 2023, 15:e41120. 10.7759\/cureus.41120","journal-title":"Cureus"},{"key":"ref36","unstructured":"NICE. Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel. (2013). Accessed. 23 August 2020: https:\/\/www.nice.org.uk\/guidance\/dg11\/chapter\/1-Recommendations..."},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1136\/fg.2010.001362","article-title":"Measurement of faecal calprotectin and lactoferrin in inflammatory bowel disease","volume":"2","author":"Lamb CA","year":"2011","unstructured":"Lamb CA, Mansfield JC. Measurement of faecal calprotectin and lactoferrin in inflammatory bowel disease. Frontline Gastroenterol. 2011, 2:13-8. 10.1136\/fg.2010.001362","journal-title":"Frontline Gastroenterol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.11.059","article-title":"Microbial influences in inflammatory bowel diseases","volume":"134","author":"Sartor RB","year":"2008","unstructured":"Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology. 2008, 134:577-94. 10.1053\/j.gastro.2007.11.059","journal-title":"Gastroenterology"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1097\/01.MIB.0000200323.38139.c6","article-title":"Specificities of the fecal microbiota in inflammatory bowel disease","volume":"12","author":"Sokol H","year":"2006","unstructured":"Sokol H, Seksik P, Rigottier-Gois L, et al.. Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm Bowel Dis. 2006, 12:106-11. 10.1097\/01.MIB.0000200323.38139.c6","journal-title":"Inflamm Bowel Dis"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a001651","article-title":"The nuclear factor NF-kappaB pathway in inflammation","volume":"1","author":"Lawrence T","year":"2009","unstructured":"Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009, 1:a001651. 10.1101\/cshperspect.a001651","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.24.6.2385-2396.2004","article-title":"Interleukin-10 inhibits interleukin-12 p40 gene transcription by targeting a late event in the activation pathway","volume":"24","author":"Zhou L","year":"2004","unstructured":"Zhou L, Nazarian AA, Smale ST. Interleukin-10 inhibits interleukin-12 p40 gene transcription by targeting a late event in the activation pathway. Mol Cell Biol. 2004, 24:2385-96. 10.1128\/MCB.24.6.2385-2396.2004","journal-title":"Mol Cell Biol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00072","article-title":"Toll-like receptors and inflammatory bowel disease","volume":"9","author":"Lu Y","year":"2018","unstructured":"Lu Y, Li X, Liu S, Zhang Y, Zhang D. Toll-like receptors and inflammatory bowel disease. Front Immunol. 2018, 9:72. 10.3389\/fimmu.2018.00072","journal-title":"Front Immunol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.812774","article-title":"Toll-like receptor signaling and its role in cell-mediated immunity","volume":"13","author":"Duan T","year":"2022","unstructured":"Duan T, Du Y, Xing C, Wang HY, Wang RF. Toll-like receptor signaling and its role in cell-mediated immunity. Front Immunol. 2022, 13:812774. 10.3389\/fimmu.2022.812774","journal-title":"Front Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/424346-biomarkers-of-probiotic-therapy-in-ulcerative-colitis-a-systematic-review-of-mechanisms-underlying-remission","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:06:36Z","timestamp":1793689596000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/424346-biomarkers-of-probiotic-therapy-in-ulcerative-colitis-a-systematic-review-of-mechanisms-underlying-remission"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":43,"URL":"https:\/\/doi.org\/10.7759\/cureus.96126","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,5]]}}}